Vinflunine Tartrate

CAS No. 1201898-17-0

Vinflunine Tartrate( —— )

Catalog No. M17186 CAS No. 1201898-17-0

Vinflunine Tartrat is a new vinca alkaloid uniquely fluorinated with the properties of mitotic-arresting and tubulin-interacting activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Vinflunine Tartrate
  • Note
    Research use only, not for human use.
  • Brief Description
    Vinflunine Tartrat is a new vinca alkaloid uniquely fluorinated with the properties of mitotic-arresting and tubulin-interacting activity.
  • Description
    Vinflunine Tartrat is a new vinca alkaloid uniquely fluorinated with the properties of mitotic-arresting and tubulin-interacting activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    Microtubules
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1201898-17-0
  • Formula Weight
    967.02
  • Molecular Formula
    C45H54F2N4O8·xC4H6O6
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 45 mg/mL. 46.53 mM
  • SMILES
    CC[C@@]12C=CCN3[C@@H]1[C@]4(CC3)[C@H]([C@]([C@@H]2OC(=O)C)(C(=O)OC)O)N(C5=CC(=C(C=C45)[C@]6(C[C@H]7C[C@H](CN(C7)CC8=C6NC9=CC=CC=C89)C(C)(F)F)C(=O)OC)OC)C.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ngan VK, et al, Cancer Res, 2000, 60(18), 5045-5051.
molnova catalog
related products
  • Feladilimab

    Feladilimab (GSK3359609) is an IgG4 monoclonal antibody that is an ICOS agonist.

  • 4-Hydroxyantipyrine

    Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver.

  • Mollugin

    Mollugin may be a JAK2 inhibitor and inhibits LPS-induced inflammatory responses by blocking the activation of the JAK-STAT pathway.